Table 3 Deterioration of glycemic control positively correlated with increased GDI

HbA1c (%)

6.28 ± 0.76

8.58 ± 1.66

9.55 ± 1.85

10.40 ± 0.85

P<0.001^#

GA (%)

15.14 ± 2.77

23.82 ± 6.11

27.75 ± 6.21

30.73 ± 5.87

P<0.01^*

log-FBG^a (mmol/L)

0.79 ± 0.10 (6.23 ± 1.30)

0.84 ± 0.06 (6.98 ± 0.88)

0.92 ± 0.08 (8.54 ± 1.71)

1.02 ± 0.11 (10.76 ± 2.64)

P<0.001^*

MBG (mmol/L)

7.00 ± 0.27

7.88 ± 0.63

10.96 ± 1.13

13.55 ± 1.56

P<0.001^*

sqrt-AUC_H-L^b (mmol/L∙ day)

0.48 ± 0.32 (0.31 ± 0.21)

0.93 ± 0.20 (0.90 ± 0.39)

1.79 ± 0.23 (3.27 ± 0.79)

2.40 ± 0.29 (5.83 ± 1.53)

P<0.001^*

SDBG (mmol/L)

1.06 ± 0.36

2.08 ± 0.50

2.77 ± 0.77

3.32 ± 1.01

P<0.001^*

MAGE (mmol/L)

2.15 ± 0.55

3.98 ± 1.15

4.84 ± 1.49

5.27 ± 1.52

P<0.01^*

MODD (mmol/L)

1.07 ± 0.47

2.07 ± 0.76

2.68 ± 0.55

3.41 ± 1.06

P<0.01^#